Orsay Virus Infection of Caenorhabditis elegans Is Modulated by Zinc and Dependent on Lipids
ABSTRACT
Viruses utilize host lipids to promote the viral life cycle, but much remains unknown as to how this is regulated. Zinc is a critical element for life, and few studies have linked zinc to lipid homeostasis. We demonstrated that Caenorhabditis elegans infection by Orsay virus is dependent upon lipids and that mutation of the master regulator of lipid biosynthesis, sbp-1, reduced Orsay virus RNA levels by ~236-fold. Virus infection could be rescued by dietary supplementation with lipids downstream of fat-6/fat-7. Mutation of a zinc transporter encoded by sur-7, which suppresses the lipid defect of sbp-1, also rescued Orsay virus infection. Furthermore, reducing zinc levels by chemical chelation in the sbp-1 mutant also increased lipids and rescued Orsay virus RNA levels. Finally, increasing zinc levels by dietary supplementation led to an ~1,620-fold reduction in viral RNA. These findings provide insights into the critical interactions between zinc and host lipids necessary for virus infection.
IMPORTANCE Orsay virus is the only known natural virus pathogen of Caenorhabditis elegans, which shares many evolutionarily conserved pathways with humans. We leveraged the powerful genetic tractability of C. elegans to characterize a novel interaction between zinc, lipids, and virus infection. Inhibition of the Orsay virus replication in the sbp-1 mutant animals, explained by the lipid depletion, can be rescued by a genetic and pharmacological approach that reduces the zinc accumulation and rescues the lipid levels in this mutant animal. Interestingly, the human ortholog of sbp-1, srebp-1, has been reported to play a role for virus infection, and zinc has been shown to inhibit the virus replication of multiple viruses. However, the mechanism through which zinc is acting is not well understood. These results suggest that the lipid regulation mediated by zinc may play a relevant role during mammalian virus infection.
INTRODUCTION
Viruses continue to be a global threat to human, animal, and plant health. Although significant advances have been achieved in understanding host-virus interactions, there are still many questions unanswered. Caenorhabditis elegans is an animal model with many genes and biological processes that are evolutionarily conserved in higher eukaryotes. Thus, many fundamental discoveries in this model organism have been extrapolated into humans, such as apoptosis, RNA interference (RNAi), and microRNAs (1–3). Likewise, in recent years, C. elegans has become a model to study virus-host interactions following the discovery of Orsay virus, the first known natural virus of this organism (4, 5). This in vivo infection system has enabled the identification of novel host factors required for viral infection (6–10). Further characterization of host-virus interactions by employing this genetically tractable model provides the opportunity to elucidate underlying mechanisms utilized by viruses to proliferate.
Orsay virus is a nonenveloped, single-stranded, positive-sense RNA virus related to viruses in the family Nodaviridae (4). The genome of Orsay virus is composed of two RNA segments, the first of which encodes an RNA-dependent RNA polymerase (RdRp) in the RNA1 segment (~3.4 kb). The RNA2 segment (~2.5 kb) encodes the viral capsid and a capsid-delta fusion protein that is generated by a ribosomal frameshifting mechanism (11). The Orsay capsid has a T=3 icosahedral symmetry with 60 trimeric surface spikes (12). In addition, a plasmid-based genetic reverse system was developed by generating transgenic animals harboring the Orsay virus cDNAs (13). Orsay virus infects primarily intestinal cells, which leads to morphological changes of the intestine including fusion of intestinal cells, induction of vesicles, and disappearance of nuclei (4, 14). Little is known about the host factors required for Orsay virus infection in C. elegans. A few genes, sid-3, viro-2, nck-1, drl-1, and hipr-1, essential for Orsay virus infection that act on early, prereplication stages of the virus life cycle have been identified (6, 9, 10).
Viruses depend on host cells to produce viral proteins, replicate their genome, and assemble infectious particles to complete their viral life cycle. The building blocks and energy required for viruses are provided by the host cell. RNA viruses exploit the membranes and intracellular lipids of the host during infection (15–18). One example is rotavirus, for which it was shown that colocalization of the lipid droplets (LDs) with the replication center and drugs that interfere with LD formation inhibited the viral RNA replication and production of viral progeny (19). In addition, it has been shown that LDs are important in replication for multiple viruses like hepatitis C virus (HCV) (20), dengue virus (21), picornaviruses (22, 23), noroviruses (24), SARS-CoV-2 (25–27), and DNA viruses like Marek’s disease virus (28). Understanding the mechanisms employed by viruses to disrupt and exploit lipid metabolism may provide means to develop countermeasures against viruses.
The sterol-regulatory-element-binding protein (srebp) is a transcription factor that belongs to the basic helix-loop-helix leucine zipper family and is important for the homeostasis of lipids in the cell. In mammals, there are two srebp genes, srebp1 and srebp2. srebp1 is mainly involved in the expression of fatty acid biosynthesis genes whereas srebp2 is involved in cholesterol biosynthesis (29). During the maturation of these proteins, the newly synthesized srebp is located in the endoplasmic reticulum (ER) membrane as a precursor. When specific cellular lipids are low, the protein is transported to the Golgi complex and released by proteases. Then, the mature srebp is translocated into the nucleus, where it induces the transcription of more than 30 lipogenic genes (30). As srebp has a vital role in cellular lipid metabolism, many viruses have subverted this transcription factor according to their needs. For example, it has been described that HCV (31–34), coxsackievirus B3 (CVB3) (35, 36), and human cytomegalovirus (37, 38) promote the accumulation of lipids through induction of the srebp pathway. Likewise, it has been reported that multiple viruses require lipids for efficient infection: SARS-CoV-2 and Ebola virus require cholesterol for viral entry (39–41), dengue virus requires triglycerides as an energy source through β-oxidation (42), and enteroviruses and flaviviruses require phosphatidylinositol-4-phosphate (PI4P) in the replication center for viral RNA replication (43).
In C. elegans the ortholog of human srebp1 is sbp-1, and there is no ortholog of srebp2 (44). sbp-1 is involved in the regulation of lipogenic enzymes grouped in three main branches that generate the lipid precursors for the cell: the stearoyl-coenzyme A (CoA) desaturases fat-6/fat-7, the stearoyl-coenzyme A desaturase fat-5, and the monomethyl branched-chain fatty acids elo-5/elo-6 (45). RNA interference knockdown of sbp-1 or mutations in the sbp-1 gene lead to animals with low fat stores, high saturated fatty acid content, and reduced expression of lipogenic genes (44, 46–48). Interestingly, mutation of sbp-1 in C. elegans also leads to ~2-fold accumulation of zinc (49). A genetic suppressor screen identified that mutation in sur-7, which encodes a member of the cation diffusion facilitator family, reduces the accumulation of zinc in sbp-1 mutants and also restores lipid levels (49), suggesting there is a link between zinc and lipid homeostasis. Only limited prior studies have investigated linkages between zinc and lipids. For example, zinc induces lipophagy in primary hepatocytes of yellow catfish (50), zinc levels are reduced in patients with alcoholic fatty liver disease (51), zinc supplementation reduces total cholesterol and triglycerides as found in a meta-analysis of 24 studies on humans, and zinc reverses alcoholic steatosis in mice (52). Related to virus infection, antiviral effects of zinc supplementation against multiple viruses, including herpesviruses (53), picornaviruses (54, 55), influenza virus (56), coronavirus (57), HCV (58–60), and HIV (61, 62), have been described. While different mechanisms have been proposed to explain the putative antiviral effect of zinc, including inhibition of viral protein cleavage and inhibition of viral polymerase activity (54, 55, 57), experimental data for these models are lacking, and it is not clear how zinc impacts virus infection.
Here, we show in vivo the impact of Orsay virus on lipid homeostasis as well as its dependence on lipid levels. We found that multiple transcription factors involved in lipid homeostasis play roles during Orsay virus infection, including the master regulator srebp-1/sbp-1. The reduced Orsay virus RNA levels in sbp-1 mutant animals could be rescued biochemically by supplementation with specific lipids, genetically by introduction of the suppressor gene sur-7, and by pharmacological treatment with a chelator of zinc, TPEN [N,N,N′,N′-tetrakis(2-pyridylmethyl)ethane-1,2-diamine]. Finally, direct treatment of wild-type (WT) animals with zinc reduced Orsay virus RNA levels. In these studies, we were able to observe correlated changes in lipid abundance and Orsay virus RNA levels, demonstrating a connection between zinc, lipids, and virus infection.
RESULTS
Orsay virus infection reduced lipid levels in live animals.
To examine the possibility that Orsay virus infection alters lipid levels in C. elegans, we quantified lipid abundance in live animals by lipid staining and microscopy. We employed a previously described transcriptional reporter strain, jyls8;rde-1(ne219), which is hypersensitive to Orsay virus and carries an integrated transcriptional green fluorescent protein (GFP) reporter driven by the pals-5 promoter that is induced by Orsay virus and enables visualization of viral infection by fluorescence microscopy (6). Animals were fed the fluorescent dye LipidTox, which binds to neutral lipids such as triacylglycerols (63–65), and assayed at 48 h postinfection (hpi). Lipid abundance was significantly reduced by ~60% in animals that were infected with Orsay virus compared to noninfected control animals (Fig. 1). Similar reduction was observed following staining of animals with a different lipid staining dye, oil red O (ORO) (see Fig. S1 in the supplemental material). One possibility about this reduction is that lipids interfere with viral replication, and Orsay virus gets rid of lipids to help itself. In this case, reducing lipids will help the virus replicate. Another possibility is that lipids are necessary for replication and are depleted by viral activity. In this case, reducing lipids will blunt viral replication.
FIG 1
Transcription factors that regulate lipid homeostasis are important for Orsay virus infection.
To determine whether Orsay virus depends on lipids for infection, we quantified Orsay virus RNA levels in animals depleted of lipids. First, we used RNA interference to knock down the major transcription factors, sbp-1, nhr-80, nhr-49, daf-3, and daf-16, as well as the transcriptional mediator mdt-15, known to be involved in the lipid biosynthesis of C. elegans (66). RNAi knockdown of sbp-1 and mdt-15 reduced the Orsay virus RNA levels by ~14- and ~21-fold, respectively, at 48 hpi compared to the control, empty RNAi feeding vector or knockdown of an irrelevant gene, dpy-3 (Fig. 2A). To corroborate this finding, we tested animals carrying defined mutations in these genes that were available from the Caenorhabditis Genetics Center (CGC). We demonstrated that mutants in nhr-49(ok2165 and nr2041), daf-3(ok3610 and m3D790), daf-16(m486 and mgDF50), and mdt-15(tm2182) displayed viral RNA levels that were reduced ~16-, ~14.5-, ~11.6-, and ~23.6-fold, respectively (Fig. 2B). Of all the mutants we tested, only nhr-80(tm1011) did not display reduced viral RNA levels. Interestingly, sbp-1(ep79), which has a deletion of 2.1 kb resulting in partial loss of function (67), caused the strongest phenotype with an ~236-fold reduction of Orsay virus viral RNA (Fig. 2B). These results suggest that Orsay virus requires lipids for an efficient infection and that the evolutionarily conserved master regulator sbp-1(ep79) is playing a major role during Orsay virus infection in C. elegans.
FIG 2
To unambiguously demonstrate that the viral phenotype in the sbp-1(ep79) mutant is due to SBP-1, we evaluated Orsay virus infection in a transgenic sbp-1(ep79) strain that overexpresses SBP-1 fused to GFP (sbp-1::GFP::SBP-1, CE548) (68). First, we evaluated the recovery of lipid production in the sbp-1::GFP::SBP-1 strain; for this, we performed lipid staining and found that the mutation increased lipid levels ~3.7-fold compared to sbp-1(ep79) (Fig. 2C and D). Likewise, when we challenged the sbp-1::GFP::SBP-1 strain with Orsay virus, it displayed viral RNA levels restored to those of wild-type animals (Fig. 2E). This result demonstrates the specific role of sbp-1 and reinforces the idea that lipids promote Orsay virus infection in C. elegans.
Genetic analysis of the sbp-1 pathway identified a role for the fat-6/fat-7 and elo-5/elo-6 branches during Orsay virus infection.
sbp-1 is a transcriptional activator of the expression of multiple lipogenic enzymes in three different branches (Fig. 3A) (30, 45). To identify which branch(es) regulated by sbp-1 is important for Orsay virus infection, we performed an RNA interference-mediated knockdown of representative lipogenic genes from every branch (Fig. 3A and B). Knockdown of fat-6 and fat-7, which encode stearoyl-coenzyme A (CoA) desaturases and which function redundantly to synthesize oleic acid from stearic acid, reduced the Orsay virus RNA levels; however, knockdown of elo-2, which is involved in the synthesis of stearic acid, or the pathways represented by fat-5 or elo-5 and elo-6 did not alter Orsay virus RNA levels.
FIG 3
As the levels of knockdown by RNAi are likely to be incomplete (69), we challenged mutant animals that lacked these same genes with Orsay virus, except for elo-2, which is an essential gene (70). The fat-6(tm331);fat-7(wa36) double mutant animals, which are deficient in oleic acid production (71, 72), had ~5-fold-reduced Orsay virus RNA levels. No phenotype was observed for the fat-5(tm420) mutant animals, which are deficient in the production of palmitoleic acid (72), which suggests that the lipids from this branch are not critical for Orsay virus infection. Interestingly, in the elo-5(gk182) and elo-6(gk233) mutant animals Orsay virus RNA levels were reduced by ~65-fold and ~10-fold, respectively (Fig. 3C), in contrast to the RNAi results in which gene expression was knocked down but not ablated.
A biochemical screen of the sbp-1 pathway identified lipids that rescue Orsay virus infection.
In the sbp-1(ep79) mutant, there is accumulation of the saturated fatty acid stearic acid, whereas several lipid products like oleic acid and linoleic acid, or monomethyl branched-chain fatty acids like C15iso and C17iso are reduced (48, 67). To determine which lipid(s) was limiting in the sbp-1(ep79) mutant for Orsay virus infection, we biochemically supplemented the animals with a range of lipids. After 3 days postinfection (dpi), the animals were collected, and the viral RNA was quantified by quantitative reverse transcription-PCR (qRT-PCR). As expected, feeding with stearic acid had no impact on sbp-1(ep79) animals, as stearic acid is upstream of the genes regulated by sbp-1. Likewise, we did not find rescue of the viral RNA levels for animals fed with oleic acid or linoleic acid (Fig. 4B and C). The lipids α-linoleic acid, γ-linoleic acid, and dihomo-γ-linoleic acid completely rescued the viral RNA levels to wild-type (WT) levels (Fig. 4D, E, and G). However, supplementation with lipids like eicosatetraenoic acid had complex effects and also reduced the viral RNA levels in WT animals (Fig. 4H). Furthermore, lipid supplementation with arachidonic or eicosapentaenoic acid did not rescue the viral RNA levels (Fig. 4I and J). In addition, the lipids C15iso and C17iso from the elo-5/elo-6 branch did not rescue the viral RNA levels (Fig. 4K to M). These results demonstrate that supplementation with specific lipids in the sbp-1 background can rescue Orsay virus infection.
FIG 4
sbp-1 functions at the replication stage of the Orsay virus life cycle.
Because the depletion of lipids can impact many stages of the viral life cycle, we sought to determine whether sbp-1(ep79) mutation was directly affecting the viral replication step of the Orsay virus life cycle. We employed a previously described replicon system for Orsay virus based on an extrachromosomal array of plasmids of the entire Orsay virus WT RNA1 segment that encodes a WT RNA-dependent RNA viral polymerase (RdRp) (WUM104 [N2;PHIP::RNA1WT]) under a heat shock promoter (6, 9, 13). Strains harboring RNA1 alone are competent to support replication of the Orsay virus RNA1 segment following heat shock induction. Also, as a control to determine the level of Orsay virus RNA generated by DNA-templated transcription, a transgenic wild-type strain carrying extrachromosomal arrays of a D601A polymerase-dead mutant of Orsay virus RNA1 (WUM106 [N2;PHIP::RNA1D601A]) was also generated. These transgenic strains were crossed with the sbp-1(ep79) mutant to generate the replicon system in this background and compare the viral RNA levels of this strain with those of wild-type animals. The replicon system was induced by heat shock, and the Orsay virus RNA levels were quantified by qRT-PCR. In the sbp-1(ep79) mutant carrying the RNA1 WT replicon {WUM108 [sbp-1(ep79);PHIP::RNA1WT]}, there is no statistical difference from WUM110 [sbp-1(ep79);PHIP::RNA1D601A], and these viral RNA levels were ~55-fold lower than those of the N2;PHIP::RNA1WT animals (Fig. 5 and Fig. S2). These results suggest that sbp-1 is necessary for Orsay virus replication. This analysis does not rule out the possibility that sbp-1 may also act at other stages of the Orsay virus life cycle.
FIG 5
Zinc impacts lipid levels and Orsay virus infection in wild-type and sbp-1(ep79) mutant animals.
The observation that specific lipids can rescue Orsay virus infection in the sbp-1(ep79) mutant demonstrated that lipid deficiency of the sbp-1 mutant is important. However, the factors involved in lipid homeostasis are still not clear. Interestingly, a forward genetic screen identified sur-7 as a suppressor of the sbp-1(ep79) mutant that restores lipid levels (49). sur-7 encodes a member of the cation diffusion facilitator family and is involved in zinc metabolism (73, 74). To investigate if the mutation in sur-7(ku119) could rescue the lipid levels in the sbp-1(ep79) mutant, we performed LipidTox staining. We confirmed that the sur-7(ku119);sbp-1(ep79) double mutant rescued lipid levels to those of wild-type animals (Fig. 6A and B). Staining with ORO also demonstrated a significant increase in lipid levels in the sur-7(ku119);sbp-1(ep79) background compared to sbp-1(ep79) (Fig. S3). Likewise, to investigate if the virus infection in the sbp-1(ep79) mutant could be rescued, we challenged the sur-7(ku119);sbp-1(ep79) double mutant animals with Orsay virus. Orsay virus RNA levels in the double mutant were increased compared to the sbp-1(ep79) mutant and similar to those of wild-type animals (Fig. 6C).
FIG 6
Because it is known that mutation of sbp-1 in C. elegans leads to accumulation of zinc, and sur-7 suppresses both the increased zinc and decreased lipid phenotypes in the sbp-1 mutant (49), we used a pharmacological strategy to specifically deplete the zinc levels in the sbp-1(ep79) mutant. If a high concentration of zinc is depleting the lipid levels in the sbp-1(ep79) mutant and this is reducing the Orsay virus infection, then reduction of zinc levels in the sbp-1(ep79) mutant should rescue the lipid production and rescue the virus infection. If zinc is not important for lipid homeostasis, then zinc depletion should not rescue the lipid levels and the Orsay virus infection. Addition of TPEN, a membrane-permeant zinc chelator (49, 75), to the medium increased the lipid levels in the sbp-1(ep79) mutant up to ~2.6-fold (Fig. 6D and E). Likewise, TPEN treatment rescued the Orsay virus RNA levels in the sbp-1(ep79) mutant to levels similar to those in wild-type animals (Fig. 6F). This result suggests that high concentrations of zinc in the sbp-1(ep79) mutant play a role in the reduction of the lipid levels, thereby preventing efficient Orsay virus infection (hypothetical model shown in Fig. 7). Thus, Orsay virus infection of the sbp-1 mutant could be rescued by multiple approaches: (i) ectopic supplementation of various lipids, (ii) mutation of the sur-7 gene, and (iii) pharmacological depletion of zinc with TPEN.
FIG 7
Since reducing zinc levels helps to recover the Orsay virus infection, this suggests that increasing the zinc concentration might hurt the virus. We tested this prediction and supplemented zinc into the medium of wild-type N2 animals. Supplementation of zinc in wild-type animals reduced the viral RNA levels ~1,620-fold compared to their respective controls in standard medium (Fig. 6G). Treatment with a different divalent cation, manganese (Mn), reduced the viral RNA levels by only ~8-fold in the wild-type animals, demonstrating a marked impact of zinc (hypothetical model in Fig. 7).
DISCUSSION
The genetic tractability of C. elegans and its conservation of many pathways with mammals make it an excellent reductionist model to explore host-virus interactions. Use of Orsay virus enables the study of host-virus interactions in vivo in a natural multicellular host. Here, we explored the role of lipids in Orsay virus infection. We demonstrate that Orsay virus impacts lipid homeostasis by reducing the amount of lipids ~60% by 48 hpi in animals, suggesting that Orsay virus alters lipid metabolism during viral infection. Interestingly, in human cells, dengue virus similarly reduces lipid abundance by 60% at 24 to 48 hpi (42).
The dependence of Orsay virus on lipids is also supported by assessing the impact of genetic approaches to depleting lipids. Animals with mutations of multiple transcription factors as well as RNAi knockdown of those transcription factors had reduced Orsay virus RNA levels. Although by RNAi we observed phenotypes for only sbp-1 and mdt-15, defined mutants of additional transcription factors also led to lower Orsay virus RNA levels, most likely due to incomplete knockdown by RNAi. The observed dependence of Orsay virus in C. elegans on lipids parallels the observation that depletion of lipids reduces infection by many pathogenic mammalian viruses, including SARS-CoV-2 (76), hepatitis C virus (77), Zika virus (78), poliovirus (PV) (79), and encephalomyocarditis virus (EMCV) (80). Thus, Orsay virus infection of C. elegans may serve as a robust model of these interactions.
As sbp-1 is involved in the expression of many lipogenic genes, we sought to determine which lipid biosynthetic genes and corresponding lipid molecules are required during infection. We found genetically that of the three branches regulated by sbp-1, the fat-6/fat-7 and elo-5/elo-6 branches affected Orsay virus infection but the fat-5 pathway did not. sbp-1(ep79) mutants accumulate fatty acids like palmitic and palmitoleic acid, which belong to the fat-5 branch, but have reduced levels of oleic acid, linoleic acid, and C15iso/C17iso, which correspond to the fat-6/fat-7 and elo-5/elo-6 branches, respectively (48, 67). Feeding the sbp-1(ep79) mutants biochemically with multiple lipids from the fat-6/fat-7 branch, including α-linoleic acid and γ-linoleic acid and dihomo-γ-linoleic acid, rescued viral RNA levels, but stearic acid, arachidonic acid, C15iso, or C17iso did not. The inability of stearic acid to rescue is predicted since stearic acid is the precursor of the fat-6/fat-7 enzymes and the sbp-1(ep79) mutant accumulates stearic acid. The observation that multiple lipids downstream of fat-6/fat-7 rescued Orsay virus RNA levels confirms the importance of this branch of lipid metabolism for Orsay virus. We did not observe rescue of the sbp-1(ep79) mutant by supplementation of C15iso or C17iso even though mutants with mutations in elo-5 and elo-6, the genes that synthesize these two lipids, respectively, have lower levels of Orsay virus infection. One possible explanation is that in the sbp-1(ep79) mutant there is a reported 50% reduction in the C15iso/C17iso lipid levels whereas in elo-5 and elo-6 mutants, which have a deletion of 379 bp and 184 bp of the first exon, respectively, the reduction is likely to be greater; therefore, the levels of these two lipids may not be limiting factors in the sbp-1 background (67).
Lipids could be required for one or more steps of the Orsay virus life cycle, such as viral entry, proper release and trafficking of infectious particles into the cytoplasm, replication of viral RNA, viral assembly, or egress. To better define the stage at which sbp-1 acts, we specifically assessed viral replication by employing an in vivo replicon system where Orsay virus replication is initiated from an inducible integrated transgene (6). We found that virus RNA levels were reduced in the sbp-1(ep79) mutant, indicating that one or more lipids regulated by sbp-1 are needed for virus RNA replication. While a number of studies have defined the importance of srebp-1, the human ortholog of sbp-1, for viral infection, none of the studies have implicated a specific stage of the viral life cycle that is dependent on srebp1 (32, 35, 37, 81). Thus, our findings demonstrate that the step of viral RNA replication is affected in the sbp-1(ep79) mutant, although it is possible that additional other steps of the viral life cycle may be also affected.
These findings demonstrate that specific lipids regulated by sbp-1 are important for Orsay virus infection. The exact mechanism by which these lipids are necessary for an efficient virus replication is still unknown, but several possibilities center on roles involving the viral replication center. It has been shown that oleic acid plays a role in the viral replication step of hepatitis C virus (HCV), as its depletion disrupts the integrity of membranous HCV replication centers and renders HCV RNA susceptible to nuclease-mediated degradation (82). Another possibility is that the lipids could be the precursors for components of the replication center that help to recruit the RdRp. Such is the case for coxsackievirus B3 (CVB3) and poliovirus (PV) RNA polymerases that show a high affinity for PI4P lipids (43) or the p92 RNA polymerase from tomato bushy stunt virus (TBSV), which recognizes phosphatidylethanolamine (PE) to form a complex associated with the membrane of peroxisomes (83). Alternatively, or in addition, lipids can directly modulate viral enzymatic activities. For example, the autocatalytic cleavage of the PV 3CDpol proteins, which are the precursors of the polymerase (3Dpol) and protease 3C, is attenuated when bound to PI4P lipids (84). Likewise, it has been shown that PE stimulates the enzymatic activity of TBSV viral polymerase and enhances its association with viral RNA (83), whereas binding to phosphatidylglycerol lipids inhibits its activity (85). The ability of some lipids, but not others, to rescue Orsay virus infection in C. elegans provides an opportunity to further dissect the precise biochemical interactions required for virus infection. More studies of the localization of the critical lipids, as well as their downstream products, are necessary to understand how Orsay virus affects and is dependent upon lipid metabolism in vivo.
One strength of the C. elegans system is its genetic tractability, which enables detailed dissection of pathways by genetic approaches including suppressor screens. A previous suppressor screen of the sbp-1(ep79) mutant lipid defect found that mutation of sur-7, which encodes a transporter of zinc, restores lipid homeostasis (49). We found that mutation of sur-7 rescued the lipid levels as well as the Orsay virus infection in the sbp-1 background. These results suggested that zinc might be playing a role in the homeostasis of lipids and thus affecting the virus infection. In concordance with this hypothesis, zinc chelation in the sbp-1 background rescued both lipid levels and Orsay virus infection. It is only due to the unbiased nature of the forward genetic suppressor screening that this linkage between zinc, lipid homeostasis, and virus infection was hypothesized. Interestingly, other papers have shown a correlation between zinc and lipids (50, 86), and antiviral effects of zinc supplementation against multiple mammalian viruses have been described (53–55, 57, 61, 87, 88). Although some mechanisms have been proposed to explain the role of zinc during virus infection, like the inhibition of viral protein cleavage and processing as well as inhibition of the viral polymerase activity, the experimental data supporting these mechanistic models are lacking (54, 55, 57). Interestingly, the importance of lipids for many of these zinc-sensitive viruses including coronaviruses (26, 89), picornaviruses (43, 90), and hepatitis E virus (91), has been reported. Our collective data support a novel hypothetical mechanistic model wherein zinc reduces virus infection via the depletion of lipids and may have broad implications for zinc-sensitive viruses (Fig. 7). In addition, this reaffirms the great potential of model organism studies to elucidate novel mechanisms and dissect pathways that are broadly important across host species.
MATERIALS AND METHODS
C. elegans culture and maintenance.
C. elegans N2 (wild-type), CE548 (SBP-1:GFP), drh-1(ok3495), sbp-1(ep79), nhr-49(ok2165 and nr2041), daf-3(ok3610 and mgDf90), daf-16(mu86 and mgDf50), mdt-15(tm2182), nhr-80(tm1011), fat-5(tm420), fat-6(tm331);fat-7(wa36), elo-5(gk182), elo-6(gk233), and sur-7(ku119) strains were obtained from the Caenorhabditis Genetics Center (CGC); these strains were maintained under standard lab culture conditions unless otherwise specified. In brief, animals were fed Escherichia coli OP50 on nematode growth medium (NGM) dishes in a 20°C incubator and moved every 3 days to a new NGM dish seeded with E. coli OP50 (92).
Orsay virus preparation, infection, and RNA extraction.
Orsay virus was prepared by liquid culture as described previously (11), filtered through a 0.22-μm filter, and stored at −80°C. For all infection experiments, animals were bleached and then synchronized in M9 buffer (1) in 15-mL conical tubes with constant rotation at room temperature for 18 h. In a six-well dish with E. coli OP50, 500 arrested larval-stage 1 (L1) larvae were seeded. L1 larvae were allowed to recover for 20 h at 20°C prior to infection. Orsay virus filtrate was thawed at room temperature and then diluted 1:10 with M9 buffer. For each well, 20 μL of 2.5 × 105 tissue culture infective doses (TCID50)/mL (multiplicity of infection [MOI] of 10) of virus filtrate was added into the middle of the bacterial lawn and incubated at 20°C. Three days after infection, animals were collected into 1.5-mL Eppendorf tubes by washing each well with 1 mL of M9 buffer and then pelleted by spinning for 1 min at 376 × g in a benchtop centrifuge. M9 supernatant was removed, 300 μL TRIzol reagent (Invitrogen) was added to the tubes, and then the tubes were frozen in liquid nitrogen. For each experiment, three replicate wells were used for each infection condition unless otherwise indicated. Total RNA from infected animals was extracted using Direct-zol RNA miniprep (Zymo Research) purification according to the manufacturer’s protocol and eluted into 30 μL of RNase/DNase-free water.
In vivo lipid staining.
LipidTox Red Neutral lipid (1,000×; ThermoFisher H34476) was diluted in E. coli OP50 and dispensed on NGM agar dishes to yield a final concentration of 10×. A synchronized population of the jyls8;rde-1(ne219) strain (WUM31), in stage L1, was transferred to the dish and incubated for 20 h. Then the animals were mock infected or infected with 200 μL of a 1:10 dilution of Orsay virus in M9 buffer and collected at 48 h postinfection. Twenty-five animals were transferred to 384-well plates containing 60 μL of phosphate-buffered saline (PBS) and anesthetized with 25 mM tetramisole in M9. Total fluorescence intensity was acquired with the ArrayScan V HCS reader (Cellomics, ThermoFisher). Three independent experiments were performed in duplicate, making a total of 150 animals quantified per condition. Statistical testing was done by the parametric two-tailed t test or one-way analysis of variance (ANOVA) to compare two or more than two different groups, respectively.
C. elegans RNAi feeding for knockdown.
RNAi feeding was used for gene knockdown as described previously (93). E. coli strain HT115, carrying double-stranded RNA expression cassettes for genes of interest, was induced using established conditions and then seeded into a six-well NGM dish. dpy-3, sbp-1, mdt-15, nhr-49, daf-3, daf-16, nhr-80, fat-5, fat-6, fat-7, elo-2, elo-5, and elo-6 RNAi clones were from the Ahringer RNAi library (94). Twenty arrested L1 drh-1 mutant animals were seeded into each well of a six-well dish. After 72 h of RNAi feeding, Orsay virus was added to the dishes as described above. At 48 h postinfection, the C. elegans animals were collected, and 300 μL of TRIzol (Invitrogen) was added for RNA extraction.
Orsay virus quantification by real-time qRT-PCR.
RNA extracted from infected animals was subjected to one-step real-time quantitative reverse transcription-PCR (qRT-PCR) to quantify Orsay virus RNA as previously described (13). Briefly, the extracted viral RNA was diluted 1:100, and 5 μL was used in a TaqMan fast virus one-step qRT-PCR with primers and probe (OrV_RNA2) that target the Orsay virus RNA2 segment. Absolute Orsay virus RNA2 copy number was determined by comparison to a standard curve generated using serial dilutions of Orsay virus RNA2 in vitro transcripts. Primers GW314 and GW315 and probe OrV_RNA1, which target the Orsay virus RNA1 segment, were used to quantify Orsay virus RNA1 abundance (13). To control for variation in the number of animals, Orsay virus RNA levels were normalized to an internal control gene, rps-20, which encodes a small ribosomal subunit S20 protein required for translation in C. elegans (95). At least three independent experiments in triplicate were performed. Statistical testing was done employing the Mann-Whitney test to compare two different groups of samples when indicated or the Kruskal-Wallis test to compare samples in Fig. 2C, Fig. 4, Fig. 5, Fig. 6A, D, and G, and Fig. S1 in the supplemental material. Graphic representation and statistical analyses were performed using GraphPad Prism 9 software.
Microinjection of the replicon system and analysis of the viral life cycle.
PHIP::RNA1 and PHIP::RNA1D601A mutant constructs, which encode the wild type (RNA1 WT) and dead viral polymerase (RNA1 DP), were microinjected into the gonad of animals to generate stable transgenic lines (6, 13). Briefly, 5 ng/μL of the constructs was mixed with 100 ng/μL of the transgenic marker Pmyo-3::YFP (yellow fluorescent protein) and 5 ng/μL of a 2log ladder (New England Biolabs [NEB]). C. elegans N2 young adults were injected by using a microinjection system (Zeiss). Sets of three microinjected animals were placed on E. coli OP50-seeded 6-well NGM dishes and maintained at 20°C. F1 animals displaying the fluorescent marker at the pharynx were individually transferred onto new E. coli OP50-seeded 6-well NGM dishes 3 to 5 days after injection. The stable transgenic array containing F2 animals was selected and maintained by picking 5 transgenic progeny animals each time onto a new E. coli OP50-seeded 6-well NGM dish (Table 1).
TABLE 1
| Lab designation | Strain name | Relevant genotype | Reference |
|---|---|---|---|
| WUM31 | jyIs8;rde-1(ne219) | {jyIs8[Ppals-5::GFP;Pmyo-2::mCherry]; rde-1(ne219) V} | 98 |
| WUM104 | N2;virEx64[PHIP::RNA1WT-1] | {virEx64[PHIP::OrsayRNA1WT-1; Pmyo-2::YFP]} | This paper |
| WUM105 | N2;virEx65[PHIP::RNA1WT-2] | {virEx65[PHIP::OrsayRNA1WT-1; Pmyo-2::YFP]} | This paper |
| WUM106 | N2;virEx66[PHIP::RNA1D601A-1] | {virEx66[PHIP::OrsayRNA1D601A-1; Pmyo-2::YFP]} | This paper |
| WUM107 | N2;virEx67[PHIP::RNA1D601A-2] | {virEx67[PHIP::OrsayRNA1D601A-1; Pmyo-2::YFP]} | This paper |
| WUM108 | sbp-1(ep79); virEx68[PHIP::RNA1WT-1] | {virEx68[PHIP::OrsayRNA1WT-1; Pmyo-2::YFP]; sbp-1(ep79)III} | This paper |
| WUM109 | sbp-1(ep79); virEx69[PHIP::RNA1WT-2] | {virEx69[PHIP::OrsayRNA1WT-1; Pmyo-2::YFP]; sbp-1(ep79)III} | This paper |
| WUM110 | sbp-1(ep79); virEx70[PHIP::RNA1D601A-1] | {virEx70[PHIP::OrsayRNA1D601A-1; Pmyo-2::YFP]; sbp-1(ep79)III} | This paper |
| WUM111 | sbp-1(ep79); virEx71[PHIP::RNA1D601A-2] | {virEx71[PHIP::OrsayRNA1D601A-1; Pmyo-2::YFP]; sbp-1(ep79)III} | This paper |
| WUM112 | sbp-1(ep79);sur-7(ku119) | [sbp-1(ep79) III;sur-7(ku119) X] | This paper |
| CE541 | sbp-1(ep79) | sbp-1(ep79) III | 67 |
| CE548 | sbp-1(ep79) III; epEx141 | epEx141 [sbp-1::GFP::SBP-1 + rol-6(su1006)] | 68 |
| RB2519 | drh-1(ok3495) | drh-1(ok3495) IV | 99 |
| RB1716 | nhr-49(ok2165) | nhr-49(ok2165) I | 100 |
| STE68 | nhr-49(nr2041) | nhr-49(nr2041) I | 101 |
| RB2589 | daf-3(ok3610) | daf-3(ok3610) X | 102 |
| GR1311 | daf-3(mgDf90) | daf-3(mgDf90) X | 103 |
| CF1038 | daf-16(mu86) | daf-16(mu86) I | 104 |
| GR1307 | daf-16(mgDf50) | daf-16(mgDf50) I | 105 |
| XA7702 | mdt-15(tm2182) | mdt-15(tm2182) III | 106 |
| BX165 | nhr-80(tm1011) | nhr-80(tm1011) III | 72 |
| BX107 | fat-5(tm420) | fat-5(tm420) V | 72 |
| BX156 | fat-6(tm331);fat-7(wa36) | fat-6(tm331) IV;fat-7(wa36) V | 72 |
| VC377 | elo-5(gk182) | elo-5(gk182) IV | 102 |
| VC425 | elo-6(gk233) | elo-6(gk233) IV | 102 |
| MH801 | sur-7(ku119) | sur-7(ku119) X | 73 |
The transgenic RNA1 WT or dead polymerase animals were crossed by a standard method with the sbp-1(ep79) mutants and genotyped by PCR to generate the [sbp-1(ep79);PHIP::RNA1WT] and the [sbp-1(ep79);PHIP::RNA1D601A] animals. sbp-1(ep79) mutant animals with the transgenic marker were selected and challenged with Orsay virus and assayed for virus replication by qRT-PCR.
Lipid supplementation assay.
Six-well NGM dishes were prepared with an aqueous solution of NP-40 (Sigma) to a final concentration of 0.01% and supplemented with 1 mM concentrations of any of the following reagents: stearic acid (Cayman Chemicals), oleic acid (Cayman Chemicals), linoleic acid (Cayman Chemicals), α-linoleic acid (Cayman Chemicals), γ-linoleic acid (Cayman Chemicals), stearidonic acid (Cayman Chemicals), dihomo-γ-linoleic acid (Cayman Chemicals), eicosatetraenoic acid (Cayman Chemicals), ω-3-arachidonic acid (Cayman Chemicals), arachidonic acid (Cayman Chemicals), eicosapentaenoic acid (Cayman Chemicals), C15iso (Cayman Chemicals), C17iso (Cayman Chemicals), and C13iso (Chem Cruz). Dishes without lipids were also prepared. A synchronized population of 500 L1 animals was added to the wells and incubated for 36 h. Then the animals were challenged with Orsay virus for 3 days and collected for RNA extraction and qRT-PCR. Three independent experiments in triplicate were performed.
Zinc supplementation assay.
NAMM dishes supplemented with zinc sulfate (ZnSO4) or manganese chloride (Cl2Mn) were prepared (96). A synchronized population of 500 L1 larvae was transferred into noble agar minimal media (NAMM) dishes and infected with Orsay virus as described previously. At the end of the infection, the animals were collected for RNA extraction and quantitative PCR (qPCR) analysis.
Depletion of zinc was performed by supplementing NGM agar dishes with 1 μM N,N,N′,N′-tetrakis(2-pyridylmethyl)ethane-1,2-diamine (TPEN), a zinc-specific chelator (Sigma-Aldrich) (97).
Epifluorescence microscopy.
The imaging of animals was carried out using a Zeiss Axio Imager M2 inverted fluorescence microscope equipped with a Hamamatsu Flash4.0 complementary metal oxide semiconductor (CMOS) camera for fluorescence. Briefly, animals were collected and anesthetized with 25 mM tetramisole and then put on a 2% agarose pad with a coverslip (5 by 5 cm) on top. Images were acquired from both fluorescence channels and bright-field channels.
ACKNOWLEDGMENTS
This study was supported in part by a grant from the National Institutes of Health R01AI134967 to D.W. We also thank the Consejo Nacional de Ciencia y Tecnología-Mexico (CONACyT) and Washington University in St. Louis for the funding provided for the postdoctoral stay.
Supplemental Material
File (jvi.01211-22-s0001.pdf)
- Download
- 1.01 MB
REFERENCES
1.
Brenner S. 1974. The genetics of Caenorhabditis elegans. Genetics 77:71–94.
2.
Fire A, Xu S, Montgomery MK, Kostas SA, Driver SE, Mello CC. 1998. Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans. Nature 391:806–811.
3.
Lee RC, Feinbaum RL, Ambros V. 1993. The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell 75:843–854.
4.
Felix MA, Ashe A, Piffaretti J, Wu G, Nuez I, Belicard T, Jiang Y, Zhao G, Franz CJ, Goldstein LD, Sanroman M, Miska EA, Wang D. 2011. Natural and experimental infection of Caenorhabditis nematodes by novel viruses related to nodaviruses. PLoS Biol 9:e1000586.
5.
Felix MA, Wang D. 2019. Natural viruses of Caenorhabditis nematodes. Annu Rev Genet 53:313–326.
6.
Jiang H, Chen K, Sandoval LE, Leung C, Wang D. 2017. An evolutionarily conserved pathway essential for Orsay virus infection of Caenorhabditis elegans. mBio 8:e00940-17.
7.
Jiang H, Leung C, Tahan S, Wang D. 2019. Entry by multiple picornaviruses is dependent on a pathway that includes TNK2, WASL, and NCK1. Elife 8:e50276.
8.
Le Pen J, Jiang H, Di Domenico T, Kneuss E, Kosałka J, Leung C, Morgan M, Much C, Rudolph KLM, Enright AJ, O’Carroll D, Wang D, Miska EA. 2018. Terminal uridylyltransferases target RNA viruses as part of the innate immune system. Nat Struct Mol Biol 25:778–786.
9.
Sandoval LE, Jiang H, Wang D. 2019. The dietary restriction-like gene drl-1, which encodes a putative serine/threonine kinase, is essential for Orsay virus infection in Caenorhabditis elegans. J Virol 93:e01400-18.
10.
Jiang H, Sandoval Del Prado LE, Leung C, Wang D. 2020. Huntingtin-interacting protein family members have a conserved pro-viral function from Caenorhabditis elegans to humans. Proc Natl Acad Sci USA 117:22462–22472.
11.
Jiang H, Franz CJ, Wu G, Renshaw H, Zhao G, Firth AE, Wang D. 2014. Orsay virus utilizes ribosomal frameshifting to express a novel protein that is incorporated into virions. Virology 450–451:213–221.
12.
Guo YR, Hryc CF, Jakana J, Jiang H, Wang D, Chiu W, Zhong W, Tao YJ. 2014. Crystal structure of a nematode-infecting virus. Proc Natl Acad Sci USA 111:12781–12786.
13.
Jiang H, Franz CJ, Wang D. 2014. Engineering recombinant Orsay virus directly in the metazoan host Caenorhabditis elegans. J Virol 88:11774–11781.
14.
Franz CJ, Renshaw H, Frezal L, Jiang Y, Felix MA, Wang D. 2014. Orsay, Santeuil and Le Blanc viruses primarily infect intestinal cells in Caenorhabditis nematodes. Virology 448:255–264.
15.
Stapleford KA, Miller DJ. 2010. Role of cellular lipids in positive-sense RNA virus replication complex assembly and function. Viruses 2:1055–1068.
16.
Lorizate M, Krausslich HG. 2011. Role of lipids in virus replication. Cold Spring Harb Perspect Biol 3:a004820.
17.
Richards AL, Soares-Martins JA, Riddell GT, Jackson WT. 2014. Generation of unique poliovirus RNA replication organelles. mBio 5:e00833-13.
18.
Heaton NS, Randall G. 2011. Multifaceted roles for lipids in viral infection. Trends Microbiol 19:368–375.
19.
Cheung W, Gill M, Esposito A, Kaminski CF, Courousse N, Chwetzoff S, Trugnan G, Keshavan N, Lever A, Desselberger U. 2010. Rotaviruses associate with cellular lipid droplet components to replicate in viroplasms, and compounds disrupting or blocking lipid droplets inhibit viroplasm formation and viral replication. J Virol 84:6782–6798.
20.
Bang BR, Li M, Tsai KN, Aoyagi H, Lee SA, Machida K, Aizaki H, Jung JU, Ou JJ, Saito T. 2019. Regulation of hepatitis C virus infection by cellular retinoic acid binding proteins through the modulation of lipid droplet abundance. J Virol 93:e02302-18.
21.
Chatel-Chaix L, Bartenschlager R. 2014. Dengue virus- and hepatitis C virus-induced replication and assembly compartments: the enemy inside–caught in the web. J Virol 88:5907–5911.
22.
Belov GA, van Kuppeveld FJM. 2019. Lipid droplets grease enterovirus replication. Cell Host Microbe 26:149–151.
23.
Laufman O, Perrino J, Andino R. 2019. Viral generated inter-organelle contacts redirect lipid flux for genome replication. Cell 178:275–289.e16.
24.
Doerflinger SY, Cortese M, Romero-Brey I, Menne Z, Tubiana T, Schenk C, White PA, Bartenschlager R, Bressanelli S, Hansman GS, Lohmann V. 2017. Membrane alterations induced by nonstructural proteins of human norovirus. PLoS Pathog 13:e1006705.
25.
Dias SSG, Soares VC, Ferreira AC, Sacramento CQ, Fintelman-Rodrigues N, Temerozo JR, Teixeira L, Nunes da Silva MA, Barreto E, Mattos M, de Freitas CS, Azevedo-Quintanilha IG, Manso PPA, Miranda MD, Siqueira MM, Hottz ED, Pao CRR, Bou-Habib DC, Barreto-Vieira DF, Bozza FA, Souza TML, Bozza PT. 2020. Lipid droplets fuel SARS-CoV-2 replication and production of inflammatory mediators. PLoS Pathog 16:e1009127.
26.
Nardacci R, Colavita F, Castilletti C, Lapa D, Matusali G, Meschi S, Del Nonno F, Colombo D, Capobianchi MR, Zumla A, Ippolito G, Piacentini M, Falasca L. 2021. Evidences for lipid involvement in SARS-CoV-2 cytopathogenesis. Cell Death Dis 12:263.
27.
Theken KN, Tang SY, Sengupta S, FitzGerald GA. 2021. The roles of lipids in SARS-CoV-2 viral replication and the host immune response. J Lipid Res 62:100129.
28.
Boodhoo N, Kamble N, Kaufer BB, Behboudi S. 2019. Replication of Marek’s disease virus is dependent on synthesis of de novo fatty acid and prostaglandin E2. J Virol 93:e00352-19.
29.
Horton JD, Goldstein JL, Brown MS. 2002. SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver. J Clin Invest 109:1125–1131.
30.
Horton JD, Shah NA, Warrington JA, Anderson NN, Park SW, Brown MS, Goldstein JL. 2003. Combined analysis of oligonucleotide microarray data from transgenic and knockout mice identifies direct SREBP target genes. Proc Natl Acad Sci USA 100:12027–12032.
31.
Park CY, Jun HJ, Wakita T, Cheong JH, Hwang SB. 2009. Hepatitis C virus nonstructural 4B protein modulates sterol regulatory element-binding protein signaling via the AKT pathway. J Biol Chem 284:9237–9246.
32.
Meng Z, Liu Q, Sun F, Qiao L. 2019. Hepatitis C virus nonstructural protein 5A perturbs lipid metabolism by modulating AMPK/SREBP-1c signaling. Lipids Health Dis 18:191.
33.
Waris G, Felmlee DJ, Negro F, Siddiqui A. 2007. Hepatitis C virus induces proteolytic cleavage of sterol regulatory element binding proteins and stimulates their phosphorylation via oxidative stress. J Virol 81:8122–8130.
34.
Oem JK, Jackel-Cram C, Li YP, Zhou Y, Zhong J, Shimano H, Babiuk LA, Liu Q. 2008. Activation of sterol regulatory element-binding protein 1c and fatty acid synthase transcription by hepatitis C virus non-structural protein 2. J Gen Virol 89:1225–1230.
35.
Wang L, Xie W, Zhang L, Li D, Yu H, Xiong J, Peng J, Qiu J, Sheng H, He X, Zhang K. 2018. CVB3 nonstructural 2A protein modulates SREBP1a signaling via the MEK/ERK pathway. J Virol 92:e01060-18.
36.
Xie W, Wang L, Dai Q, Yu H, He X, Xiong J, Sheng H, Zhang D, Xin R, Qi Y, Hu F, Guo S, Zhang K. 2015. Activation of AMPK restricts coxsackievirus B3 replication by inhibiting lipid accumulation. J Mol Cell Cardiol 85:155–167.
37.
Yu Y, Maguire TG, Alwine JC. 2012. Human cytomegalovirus infection induces adipocyte-like lipogenesis through activation of sterol regulatory element binding protein 1. J Virol 86:2942–2949.
38.
Yu Y, Pierciey FJ, Jr, Maguire TG, Alwine JC. 2013. PKR-like endoplasmic reticulum kinase is necessary for lipogenic activation during HCMV infection. PLoS Pathog 9:e1003266.
39.
Sanders DW, Jumper CC, Ackerman PJ, Bracha D, Donlic A, Kim H, Kenney D, Castello-Serrano I, Suzuki S, Tamura T, Tavares AH, Saeed M, Holehouse AS, Ploss A, Levental I, Douam F, Padera RF, Levy BD, Brangwynne CP. 2021. SARS-CoV-2 requires cholesterol for viral entry and pathological syncytia formation. Elife 10:e65962.
40.
Wang S, Li W, Hui H, Tiwari SK, Zhang Q, Croker BA, Rawlings S, Smith D, Carlin AF, Rana TM. 2020. Cholesterol 25-hydroxylase inhibits SARS-CoV-2 and other coronaviruses by depleting membrane cholesterol. EMBO J 39:e106057.
41.
Lee J, Kreutzberger AJB, Odongo L, Nelson EA, Nyenhuis DA, Kiessling V, Liang B, Cafiso DS, White JM, Tamm LK. 2021. Ebola virus glycoprotein interacts with cholesterol to enhance membrane fusion and cell entry. Nat Struct Mol Biol 28:181–189.
42.
Heaton NS, Randall G. 2010. Dengue virus-induced autophagy regulates lipid metabolism. Cell Host Microbe 8:422–432.
43.
Hsu NY, Ilnytska O, Belov G, Santiana M, Chen YH, Takvorian PM, Pau C, van der Schaar H, Kaushik-Basu N, Balla T, Cameron CE, Ehrenfeld E, van Kuppeveld FJ, Altan-Bonnet N. 2010. Viral reorganization of the secretory pathway generates distinct organelles for RNA replication. Cell 141:799–811.
44.
Nomura T, Horikawa M, Shimamura S, Hashimoto T, Sakamoto K. 2010. Fat accumulation in Caenorhabditis elegans is mediated by SREBP homolog SBP-1. Genes Nutr 5:17–27.
45.
Watts JL, Ristow M. 2017. Lipid and carbohydrate metabolism in Caenorhabditis elegans. Genetics 207:413–446.
46.
Kniazeva M, Crawford QT, Seiber M, Wang CY, Han M. 2004. Monomethyl branched-chain fatty acids play an essential role in Caenorhabditis elegans development. PLoS Biol 2:E257.
47.
Ashrafi K, Chang FY, Watts JL, Fraser AG, Kamath RS, Ahringer J, Ruvkun G. 2003. Genome-wide RNAi analysis of Caenorhabditis elegans fat regulatory genes. Nature 421:268–272.
48.
Yang F, Vought BW, Satterlee JS, Walker AK, Jim Sun ZY, Watts JL, DeBeaumont R, Saito RM, Hyberts SG, Yang S, Macol C, Iyer L, Tjian R, van den Heuvel S, Hart AC, Wagner G, Naar AM. 2006. An ARC/Mediator subunit required for SREBP control of cholesterol and lipid homeostasis. Nature 442:700–704.
49.
Zhang JJ, Hao JJ, Zhang YR, Wang YL, Li MY, Miao HL, Zou XJ, Liang B. 2017. Zinc mediates the SREBP-SCD axis to regulate lipid metabolism in Caenorhabditis elegans. J Lipid Res 58:1845–1854.
50.
Wei CC, Luo Z, Hogstrand C, Xu YH, Wu LX, Chen GH, Pan YX, Song YF. 2018. Zinc reduces hepatic lipid deposition and activates lipophagy via Zn(2+)/MTF-1/PPARalpha and Ca(2+)/CaMKKbeta/AMPK pathways. FASEB J 32:6666–6680.
51.
Bode JC, Hanisch P, Henning H, Koenig W, Richter FW, Bode C. 1988. Hepatic zinc content in patients with various stages of alcoholic liver disease and in patients with chronic active and chronic persistent hepatitis. Hepatology 8:1605–1609.
52.
Kang X, Zhong W, Liu J, Song Z, McClain CJ, Kang YJ, Zhou Z. 2009. Zinc supplementation reverses alcohol-induced steatosis in mice through reactivating hepatocyte nuclear factor-4alpha and peroxisome proliferator-activated receptor-alpha. Hepatology 50:1241–1250.
53.
Qiu M, Chen Y, Chu Y, Song S, Yang N, Gao J, Wu Z. 2013. Zinc ionophores pyrithione inhibits herpes simplex virus replication through interfering with proteasome function and NF-kappaB activation. Antiviral Res 100:44–53.
54.
Lanke K, Krenn BM, Melchers WJG, Seipelt J, van Kuppeveld FJM. 2007. PDTC inhibits picornavirus polyprotein processing and RNA replication by transporting zinc ions into cells. J Gen Virol 88:1206–1217.
55.
Krenn BM, Gaudernak E, Holzer B, Lanke K, Van Kuppeveld FJ, Seipelt J. 2009. Antiviral activity of the zinc ionophores pyrithione and hinokitiol against picornavirus infections. J Virol 83:58–64.
56.
Uchide N, Ohyama K, Bessho T, Yuan B, Yamakawa T. 2002. Effect of antioxidants on apoptosis induced by influenza virus infection: inhibition of viral gene replication and transcription with pyrrolidine dithiocarbamate. Antiviral Res 56:207–217.
57.
te Velthuis AJ, van den Worm SH, Sims AC, Baric RS, Snijder EJ, van Hemert MJ. 2010. Zn(2+) inhibits coronavirus and arterivirus RNA polymerase activity in vitro and zinc ionophores block the replication of these viruses in cell culture. PLoS Pathog 6:e1001176.
58.
Yuasa K, Naganuma A, Sato K, Ikeda M, Kato N, Takagi H, Mori M. 2006. Zinc is a negative regulator of hepatitis C virus RNA replication. Liver Int 26:1111–1118.
59.
Read SA, Parnell G, Booth D, Douglas MW, George J, Ahlenstiel G. 2018. The antiviral role of zinc and metallothioneins in hepatitis C infection. J Viral Hepat 25:491–501.
60.
Matsumura H, Nirei K, Nakamura H, Arakawa Y, Higuchi T, Hayashi J, Yamagami H, Matsuoka S, Ogawa M, Nakajima N, Tanaka N, Moriyama M. 2012. Zinc supplementation therapy improves the outcome of patients with chronic hepatitis C. J Clin Biochem Nutr 51:178–184.
61.
Haraguchi Y, Sakurai H, Hussain S, Anner BM, Hoshino H. 1999. Inhibition of HIV-1 infection by zinc group metal compounds. Antiviral Res 43:123–133.
62.
Fenstermacher KJ, DeStefano JJ. 2011. Mechanism of HIV reverse transcriptase inhibition by zinc: formation of a highly stable enzyme-(primer-template) complex with profoundly diminished catalytic activity. J Biol Chem 286:40433–40442.
63.
Schmokel V, Memar N, Wiekenberg A, Trotzmuller M, Schnabel R, Doring F. 2016. Genetics of lipid-storage management in Caenorhabditis elegans embryos. Genetics 202:1071–1083.
64.
Jones KT, Ashrafi K. 2009. Caenorhabditis elegans as an emerging model for studying the basic biology of obesity. Dis Model Mech 2:224–229.
65.
Klapper M, Ehmke M, Palgunow D, Bohme M, Matthaus C, Bergner G, Dietzek B, Popp J, Doring F. 2011. Fluorescence-based fixative and vital staining of lipid droplets in Caenorhabditis elegans reveal fat stores using microscopy and flow cytometry approaches. J Lipid Res 52:1281–1293.
66.
Watts JL. 2009. Fat synthesis and adiposity regulation in Caenorhabditis elegans. Trends Endocrinol Metab 20:58–65.
67.
Liang B, Ferguson K, Kadyk L, Watts JL. 2010. The role of nuclear receptor NHR-64 in fat storage regulation in Caenorhabditis elegans. PLoS One 5:e9869.
68.
Han S, Schroeder EA, Silva-Garcia CG, Hebestreit K, Mair WB, Brunet A. 2017. Mono-unsaturated fatty acids link H3K4me3 modifiers to C. elegans lifespan. Nature 544:185–190.
69.
Kamath RS, Martinez-Campos M, Zipperlen P, Fraser AG, Ahringer J. 2001. Effectiveness of specific RNA-mediated interference through ingested double-stranded RNA in Caenorhabditis elegans. Genome Biol 2:RESEARCH0002.
70.
Kniazeva M, Sieber M, McCauley S, Zhang K, Watts JL, Han M. 2003. Suppression of the ELO-2 FA elongation activity results in alterations of the fatty acid composition and multiple physiological defects, including abnormal ultradian rhythms, in Caenorhabditis elegans. Genetics 163:159–169.
71.
Watts JL, Browse J. 2000. A palmitoyl-CoA-specific delta9 fatty acid desaturase from Caenorhabditis elegans. Biochem Biophys Res Commun 272:263–269.
72.
Brock TJ, Browse J, Watts JL. 2006. Genetic regulation of unsaturated fatty acid composition in C. elegans. PLoS Genet 2:e108.
73.
Yoder JH, Chong H, Guan KL, Han M. 2004. Modulation of KSR activity in Caenorhabditis elegans by Zn ions, PAR-1 kinase and PP2A phosphatase. EMBO J 23:111–119.
74.
Davis DE, Roh HC, Deshmukh K, Bruinsma JJ, Schneider DL, Guthrie J, Robertson JD, Kornfeld K. 2009. The cation diffusion facilitator gene cdf-2 mediates zinc metabolism in Caenorhabditis elegans. Genetics 182:1015–1033.
75.
Dietrich N, Schneider DL, Kornfeld K. 2017. A pathway for low zinc homeostasis that is conserved in animals and acts in parallel to the pathway for high zinc homeostasis. Nucleic Acids Res 45:11658–11672.
76.
Chu J, Xing C, Du Y, Duan T, Liu S, Zhang P, Cheng C, Henley J, Liu X, Qian C, Yin B, Wang HY, Wang RF. 2021. Pharmacological inhibition of fatty acid synthesis blocks SARS-CoV-2 replication. Nat Metab 3:1466–1475.
77.
Mankouri J, Tedbury PR, Gretton S, Hughes ME, Griffin SD, Dallas ML, Green KA, Hardie DG, Peers C, Harris M. 2010. Enhanced hepatitis C virus genome replication and lipid accumulation mediated by inhibition of AMP-activated protein kinase. Proc Natl Acad Sci USA 107:11549–11554.
78.
Leier HC, Weinstein JB, Kyle JE, Lee JY, Bramer LM, Stratton KG, Kempthorne D, Navratil AR, Tafesse EG, Hornemann T, Messer WB, Dennis EA, Metz TO, Barklis E, Tafesse FG. 2020. A global lipid map defines a network essential for Zika virus replication. Nat Commun 11:3652.
79.
Viktorova EG, Nchoutmboube JA, Ford-Siltz LA, Iverson E, Belov GA. 2018. Phospholipid synthesis fueled by lipid droplets drives the structural development of poliovirus replication organelles. PLoS Pathog 14:e1007280.
80.
Dorobantu CM, Albulescu L, Harak C, Feng Q, van Kampen M, Strating JR, Gorbalenya AE, Lohmann V, van der Schaar HM, van Kuppeveld FJ. 2015. Modulation of the host lipid landscape to promote RNA virus replication: the picornavirus encephalomyocarditis virus converges on the pathway used by hepatitis C virus. PLoS Pathog 11:e1005185.
81.
Yuan S, Chu H, Chan JF, Ye ZW, Wen L, Yan B, Lai PM, Tee KM, Huang J, Chen D, Li C, Zhao X, Yang D, Chiu MC, Yip C, Poon VK, Chan CC, Sze KH, Zhou J, Chan IH, Kok KH, To KK, Kao RY, Lau JY, Jin DY, Perlman S, Yuen KY. 2019. SREBP-dependent lipidomic reprogramming as a broad-spectrum antiviral target. Nat Commun 10:120.
82.
Lyn RK, Singaravelu R, Kargman S, O’Hara S, Chan H, Oballa R, Huang Z, Jones DM, Ridsdale A, Russell RS, Partridge AW, Pezacki JP. 2014. Stearoyl-CoA desaturase inhibition blocks formation of hepatitis C virus-induced specialized membranes. Sci Rep 4:4549.
83.
Pogany J, Nagy PD. 2015. Activation of tomato bushy stunt virus RNA-dependent RNA polymerase by cellular heat shock protein 70 is enhanced by phospholipids in vitro. J Virol 89:5714–5723.
84.
Ilnytska O, Santiana M, Hsu NY, Du WL, Chen YH, Viktorova EG, Belov G, Brinker A, Storch J, Moore C, Dixon JL, Altan-Bonnet N. 2013. Enteroviruses harness the cellular endocytic machinery to remodel the host cell cholesterol landscape for effective viral replication. Cell Host Microbe 14:281–293.
85.
Nagy PD, Pogany J, Xu K. 2016. Cell-free and cell-based approaches to explore the roles of host membranes and lipids in the formation of viral replication compartment induced by tombusviruses. Viruses 8:68.
86.
Ranasinghe P, Wathurapatha WS, Ishara MH, Jayawardana R, Galappatthy P, Katulanda P, Constantine GR. 2015. Effects of zinc supplementation on serum lipids: a systematic review and meta-analysis. Nutr Metab (Lond) 12:26.
87.
Suara RO, Crowe JE, Jr. 2004. Effect of zinc salts on respiratory syncytial virus replication. Antimicrob Agents Chemother 48:783–790.
88.
Kaushik N, Subramani C, Anang S, Muthumohan R, Shalimar, Nayak B, Ranjith-Kumar CT, Surjit M. 2017. Zinc salts block hepatitis E virus replication by inhibiting the activity of viral RNA-dependent RNA polymerase. J Virol 91:e00754-17.
89.
Zandi M, Hosseini P, Soltani S, Rasooli A, Moghadami M, Nasimzadeh S, Behnezhad F. 2021. The role of lipids in the pathophysiology of coronavirus infections. Osong Public Health Res Perspect 12:278–285.
90.
Belov GA. 2016. Dynamic lipid landscape of picornavirus replication organelles. Curr Opin Virol 19:1–6.
91.
Glitscher M, Martin DH, Woytinek K, Schmidt B, Tabari D, Scholl C, Stingl JC, Seelow E, Choi M, Hildt E. 2021. Targeting cholesterol metabolism as efficient antiviral strategy against the hepatitis E virus. Cell Mol Gastroenterol Hepatol 12:159–180.
92.
Stiernagle T. 2006. Maintenance of C. elegans. WormBook.
93.
Ahringer J. 2006. Reverse genetics. WormBook.
94.
Kamath RS, Fraser AG, Dong Y, Poulin G, Durbin R, Gotta M, Kanapin A, Le Bot N, Moreno S, Sohrmann M, Welchman DP, Zipperlen P, Ahringer J. 2003. Systematic functional analysis of the Caenorhabditis elegans genome using RNAi. Nature 421:231–237.
95.
Melo JA, Ruvkun G. 2012. Inactivation of conserved C. elegans genes engages pathogen- and xenobiotic-associated defenses. Cell 149:452–466.
96.
Bruinsma JJ, Schneider DL, Davis DE, Kornfeld K. 2008. Identification of mutations in Caenorhabditis elegans that cause resistance to high levels of dietary zinc and analysis using a genomewide map of single nucleotide polymorphisms scored by pyrosequencing. Genetics 179:811–828.
97.
Arslan P, Di Virgilio F, Beltrame M, Tsien RY, Pozzan T. 1985. Cytosolic Ca2+ homeostasis in Ehrlich and Yoshida carcinomas. A new, membrane-permeant chelator of heavy metals reveals that these ascites tumor cell lines have normal cytosolic free Ca2+. J Biol Chem 260:2719–2727.
98.
Bakowski MA, Desjardins CA, Smelkinson MG, Dunbar TL, Dunbar TA, Lopez-Moyado IF, Rifkin SA, Cuomo CA, Troemel ER. 2014. Ubiquitin-mediated response to microsporidia and virus infection in C. elegans. PLoS Pathog 10:e1004200.
99.
Ashe A, Belicard T, Le Pen J, Sarkies P, Frezal L, Lehrbach NJ, Felix MA, Miska EA. 2013. A deletion polymorphism in the Caenorhabditis elegans RIG-I homolog disables viral RNA dicing and antiviral immunity. Elife 2:e00994.
100.
Barstead RJ, Moerman DG. 2006. C. elegans deletion mutant screening. Methods Mol Biol 351:51–58.
101.
Liu LX, Spoerke JM, Mulligan EL, Chen J, Reardon B, Westlund B, Sun L, Abel K, Armstrong B, Hardiman G, King J, McCague L, Basson M, Clover R, Johnson CD. 1999. High-throughput isolation of Caenorhabditis elegans deletion mutants. Genome Res 9:859–867.
102.
C. elegans Deletion Mutant Consortium. 2012. Large-scale screening for targeted knockouts in the Caenorhabditis elegans genome. G3 (Bethesda) 2:1415–1425.
103.
Patterson GI, Koweek A, Wong A, Liu Y, Ruvkun G. 1997. The DAF-3 Smad protein antagonizes TGF-beta-related receptor signaling in the Caenorhabditis elegans dauer pathway. Genes Dev 11:2679–2690.
104.
Lin K, Dorman JB, Rodan A, Kenyon C. 1997. daf-16: an HNF-3/forkhead family member that can function to double the life-span of Caenorhabditis elegans. Science 278:1319–1322.
105.
Ogg S, Paradis S, Gottlieb S, Patterson GI, Lee L, Tissenbaum HA, Ruvkun G. 1997. The Fork head transcription factor DAF-16 transduces insulin-like metabolic and longevity signals in C. elegans. Nature 389:994–999.
106.
Taubert S, Hansen M, Van Gilst MR, Cooper SB, Yamamoto KR. 2008. The Mediator subunit MDT-15 confers metabolic adaptation to ingested material. PLoS Genet 4:e1000021.
107.
Sergeant S, Rahbar E, Chilton FH. 2016. Gamma-linolenic acid, dihommo-gamma linolenic, eicosanoids and inflammatory processes. Eur J Pharmacol 785:77–86. https://pubmed.ncbi.nlm.nih.gov/27083549/.
Information & Contributors
Information
Published In
Journal of Virology
Volume 96 • Number 22 • 23 November 2022
eLocator: e01211-22
Editor: Rebecca Ellis Dutch, University of Kentucky College of Medicine
PubMed: 36342299
Copyright
© 2022 Casorla-Perez et al. This is an open-access article distributed under the terms of the Creative Commons Attribution 4.0 International license.
History
Received: 5 August 2022
Accepted: 16 October 2022
Published online: 7 November 2022
Keywords
Contributors
Editor
Rebecca Ellis Dutch
Editor
University of Kentucky College of Medicine
Metrics & Citations
Metrics
Note:
- For recently published articles, the TOTAL download count will appear as zero until a new month starts.
- There is a 3- to 4-day delay in article usage, so article usage will not appear immediately after publication.
- Citation counts come from the Crossref Cited by service.
Citations
Citation
2022.
Orsay Virus Infection of Caenorhabditis elegans Is Modulated by Zinc and Dependent on Lipids. J Virol
96:e01211-22.
If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. For an editable text file, please select Medlars format which will download as a .txt file. Simply select your manager software from the list below and click Download.